JGJian Guo

Jian Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jian Guo has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Distal Placement of Guide Catheter Improves Efficacy of Endovascular Thrombectomy in Large Vessel Occlusion Stroke: a Systematic Review and Meta-analysis

    by Xin Jiang, Yanbo Li, Ying Zhang, Jian Wang, Hui Lang, Jian Guo, Li He

    The impact of distal guide catheter placement on clinical outcomes for endovascular thrombectomy (EVT) in large vessel occlusion (LVO) stroke remains uncertain. This systematic review and meta-analysis aims to evaluate the efficacy and safety of distal versus proximal guide catheter placement for EVT. Following PRISMA guidelines, we systematically searched PubMed, EMBASE, and the Cochrane Library from database inception to June 15, 2025 to identify studies that directly compared clinical outcomes of distal versus proximal placement of guide catheter. We pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) using a random-effects model. The study protocol was registered on PROSPERO (CRD42024598147). A total of seven observational studies involving 1534 patients were included. Distal position of guide catheter was associated with significantly higher likelihood of first pass effect (OR, 2.16 [95% CI, 1.71-2.74]; P < 0.00001), successful recanalization (OR, 2.37 [95% CI, 1.27-4.42]; P = 0.007), and final mTICI 3 (OR, 1.53 [95% CI, 1.16-2.01]; P = 0.002). Symptomatic intracranial hemorrhage was comparable between the two groups (OR, 0.76 [95% CI, 0.38-1.51]; P = 0.43). Distal placement of guide catheter appears to be beneficial for EVT in LVO stroke, with improved procedural outcomes than those with proximal position.


  • Association between neutrophil to high-density lipoprotein ratio and futile recanalization in patients with acute ischemic stroke

    by Xin Jiang, Yidie Lin, Hui Lang, Chuang Yang, Jian Wang, Jian Guo, Li He

    Background Futile recanalization (FR) is a common and challenging phenomenon in acute ischemic stroke (AIS) patients with mechanical thrombectomy (MT). This study aimed to demonstrate the relationship of neutrophil to high-density lipoprotein ratio (NHR) and FR in AIS patients. Methods AIS patients with successful recanalization (modified Thrombolysis in Cerebral Ischemia (mTICI) score 2b–3) after MT were retrospectively analyzed. Futile recanalization was defined as modified Rankin scale (mRS) score 3–6 at 90 days even with successful recanalization. Locally estimated scatterplot smoothing (LOESS) and piecewise-linear models were conducted to investigate the association between NHR and FR. Results A total of 877 patients were included in the analyses and 487 (55.53%) of them experienced FR at 90-day follow-up. An approximate J-shaped association was detected between NHR levels and FR. When NHR levels were below 3.25, there was no evidence of association between NHR and FR. While NHR levels ranged from 3.25 to 10.65, a 1-unit increase in the NHR level was associated with a 13% decreased OR of FR (adjusted OR: 0.87; 95%CI: 0.79 to 0.96; P = 0.006). However, when NHR levels were over 10.65, a 1-unit increase in the NHR level was associated with a 30% greater adjusted OR of FR (OR: 1.30; 95%CI: 1.01 to 1.67; P = 0.041). Conclusion Our findings suggest that NHR may be a potential biomarker for FR, and provide new insights into the mechanisms of FR.


  • Dynamic Impact of Leptomeningeal Collateral Status for Hemorrhagic Transformation in Patients with Acute Ischemic Stroke with Endovascular Treatment: A Prospective Study

    by Xin Jiang, Tingting Guo, Yidie Lin, Yanbo Li, Yaowen Hu, Xin He, Ning Chen, Muke Zhou, Jian Guo

    Background Hemorrhagic transformation (HT) remains a common and serious complication after endovascular treatment (EVT) for acute ischemic stroke (AIS). Limited data exist on how dynamic status of leptomeningeal collaterals influence HT in AIS. This study aims to investigate the impact of dynamic status of leptomeningeal collaterals on postoperative HT in patients with AIS undergoing EVT. Methods A prospective cohort study was performed between January 2019 and June 2023. Only patients with middle cerebral artery occlusion who received EVT were included. Preoperative leptomeningeal collaterals were evaluated using the regional leptomeningeal collateral (rLMC) score, and postoperative collaterals were assessed using the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology score. Results A total of 342 patients with middle cerebral artery occlusion were included in this study. Multivariate analysis demonstrated that patients with good rLMC scores (˃ 10) experienced fewer HT events compared with those with poor rLMC scores (≤ 10) (adjusted odds ratio [aOR] 0.46, 95% confidence interval [CI] 0.28–0.76, P = 0.002). Further subgroup analysis based on intravenous thrombolysis showed that good leptomeningeal collaterals were significantly associated with reduced risk of HT in patients receiving bridging therapy (aOR 0.12, 95% CI 0.03–0.38, p < 0.001). Among 75 patients with incomplete recanalization, analysis of collateral changes indicated that patients with consistently good preoperative and postoperative collateral had the lowest risk of HT (aOR 0.19, 95% CI 0.04–0.95, P = 0.043). However, no significant correlation was detected between symptomatic intracranial hemorrhage and preoperative and postoperative collateral or its dynamic evolution. Conclusions Good preoperative leptomeningeal collateral status is associated with reduced risk of HT and better 90-day functional outcomes after EVT, possibly due to its role in maintaining cerebral perfusion and slowing infarct growth. Although our findings suggest that collateral-dependent infarct growth may be a potential mechanism for HT and unfavorable outcomes, this hypothesis requires further investigation.


  • Open Access

    Altered EEG Microstate Dynamics in First Unprovoked Seizure and Newly Diagnosed Epilepsy Patients

    by Kailing Huang, Deng Chen, Linyu Tian, Xintong Wu, Jinmei Li, Ling Liu, Jian Guo, Wendan Tao, Hongxi Chen, Yingying Zhang, et al.

    Objective: To identify the Electroencephalogram (EEG) microstate characteristics that can distinguish between patients with first unprovoked seizure (FUS) and newly diagnosed epilepsy (NDE), providing insight into predicting the progress of FUS to NDE, and to find the predictive biomarkers for the responsiveness to initial antiseizure medication (ASM) therapy.Methods: Fifty‐six NDE patients in a drug naïve state, 26 FUS patients, and 31 healthy controls (HCs) were compared on microstates features of 21‐channel resting‐state EEG without artifact. Four classic EEG microstates (A, B, C and D) were derived. The global explained variance (GEV), mean duration (MD), time coverage (TC), and frequency of occurrence (FO) of each microstate were calculated.Results: NDE and FUS patients exhibited decreased MD, TC, and FO in microstate C compared to the HCs. The FUS patients showed decreased MD, TC, and FO in microstate A compared to the NDE patients. Non‐seizure free (NSF) patients showed longer MD, higher TC, and FO in microstate B compared to the seizure free (SF) patients.Significance: EEG microstate serves as electrophysiological markers that can distinguish between patients with FUS and NDE. Additionally, EEG microstate parameters can also serve as the predictive biomarkers for the responsiveness to initial ASM therapy.


  • Open Access

    Neutrophil-to-albumin Ratio as a Prognostic Factor in Patients with Acute Ischemic Stroke

    by Jiajia Bao, Yang Zhang, Mengmeng Ma, Jian Wang, Xin Jiang, Jian Guo, Li He

    Background: Neutrophil-To-Albumin Ratio (NAR) is a novel inflammatory biomarker. However, the potential prognostic value of NAR in acute ischemic stroke (AIS) remains unclear. This study aimed to evaluate whether NAR levels correlated with the 3-month modified Rankin scale (mRS) in patients with AIS. Methods: AIS patients were included in this retrospective study. NAR was calculated as the ratio of absolute neutrophil count to serum albumin level. Logistic regression analyses were used to investigate the effect of NAR on 3-month mRS of AIS. The predictive values of NAR, albumin level, and neutrophil count were compared utilizing receiver operating characteristic (ROC) curves. Moreover, subgroup analyses and interaction tests were conducted to evaluate the consistency of NAR’s effect on AIS prognosis. Results: Of the 780 patients included, 403 (51.67%) had a poor clinical outcome (mRS 3-6) at 3 months. NAR was independently correlated to 3-month poor functional outcome after adjusting for confounders (Odds ratios (OR), 9.34; 95% confidence intervals (CI), 1.09 to 80.13; p =0.0417). Subgroup analysis showed a relative effect consistent with the overall population results, and no statistical interactions were found in the subgroups (all p for interaction > 0.05). The ROC curve showed that the prognosis-related cutoff value for NAR was 0.123, with corresponding specificity and sensitivity of 53.55% and 63.94%, respectively. When comparing the predictive power, NAR (0.590; 95%CI 0.549–0.630) exhibited the highest area under the curve (AUC) of ROC compared to neutrophils (0.584; 95%CI 0.543–0.624) and albumin (0.540; 95%CI 0.500–0.581). Conclusion: There is a positive relationship between NAR levels and 3-month poor functional outcomes in AIS patients, supporting the potential of NAR as a readily available and economic serum biomarker for the early identification of AIS prognosis. Further studies are required to validate the prognostic value and clinical utility of the NAR.


  • Open Access

    Morphological Features of the Vertebrobasilar System Predict Ischemic Stroke Risk in Spontaneous Vertebral Artery Dissection

    by Jiajia Bao, Mateng Bai, Muke Zhou, Jinghuan Fang, Yanbo Li, Jian Guo, Li He

    The vertebral artery’s morphological characteristics are crucial in spontaneous vertebral artery dissection (sVAD). We aimed to investigate morphologic features related to ischemic stroke (IS) and develop a novel prediction model. Out of 126 patients, 93 were finally analyzed. We constructed 3D models and morphological analyses. Patients were randomly classified into training and validation cohorts (3:1 ratio). Variables selected by LASSO — including five morphological features and five clinical characteristics — were used to develop prediction model in the training cohort. The model exhibited a high area under the curve (AUC) of 0.944 (95%CI, 0.862–0.984), with internal validation confirming its consistency (AUC = 0.818, 95%CI, 0.597–0.948). Decision curve analysis (DCA) indicated clinical usefulness. Morphological features significantly contribute to risk stratification in sVAD patients. Our novel developed model, combining interdisciplinary parameters, is clinically useful for predicting IS risk. Further validation and in-depth research into the hemodynamics related to sVAD are necessary.


  • Open Access

    Neurological complications during the Omicron COVID‐19 wave in China: A cohort study

    by Lu Lu, Lei Chen, Peiyu Wang, Zhang Qi, Yujie Chen, Xintong Wu, Xu Liu, Minjin Wang, Jinmei Li, Bo Yan, et al.

    Background and purpose: The aim was to investigate the neurological complications associated with coronavirus disease 19 (COVID‐19) during the 2022 Omicron wave.Methods and analysis: The medical records of a cohort of people admitted to neurological wards of three participating tertiary centres in Sichuan from 12 December 2022 to 12 January 2023 were reviewed. Demographics and clinical data were obtained and analysed with an interest in COVID‐19‐related new‐onset or worse neurological symptoms. The current data were also compared in two centres with similar data from the same period 12 months earlier.Results: In all, 790 people were enrolled, of whom 436 were positive for COVID‐19. Ninety‐nine had new onset COVID‐related neurological problems, or their known neurological condition deteriorated during the wave. There was a significant difference in demographics from the findings amongst admissions 12 months earlier as there was an increase in the average age, the incidence of encephalitis and encephalopathy, and mortality rates. One hundred and one received COVID‐specific antivirals, intravenous glucocorticoids and intravenous immunoglobulin therapy. No differences were seen between these and those who did not use them.Conclusion: New‐onset neurological conditions, particularly encephalitis and encephalopathy, increased significantly during this period. Deterioration of existing neurological conditions, such as seizure exacerbation, was also observed. A large‐scale treatment trial of people with COVID‐19 infection presenting with neurological disorders is still needed.


  • Open Access

    Low-to-moderate dose statins improve the functional outcome of acute ischemic stroke with conventional medication treatment

    by Jiajia Bao, Yang Zhang, Yanbo Li, Jian Guo, Li He

    Background: Low-to-moderate dose statins (LMDSs) are more commonly used among Asian acute ischemic stroke (AIS) patients in clinical practice. However, the correlation between the LMDS use and prognosis has not been evaluated in AIS patients with conventional medication treatment alone. This study aimed to investigate the influence of LMDS on the prognosis of AIS patients and how prognosis and potential prognostic factors interact with different statin doses. Methods: This retrospective cohort study included AIS patients who were admitted within 7 days after symptom onset and received conventional medication treatment alone from November 2019 to November 2020 in the Neurology, Department of West China Hospital, Sichuan University. From a total of 782 initial patients, a final cohort of 327 patients was included in the study. These patients were divided into three groups based on statin doses: non-statin (48 patients), LMDS (152 patients), and high-dose statin (HDS) (127 patients). The follow-up period was 3 months after the onset of stroke and the primary outcome was defined as a modified Rankin scale (mRS) score of 0 to 2 at 3 months, secondary outcomes were hemorrhagic transformation (HT) and death within 3 months. Stratified analysis was also conducted to test the robustness of the relationship between the use of different statin doses and functional outcomes in various subgroups. Results: Compared with non-statin therapy, both LMDS therapy and HDS therapy were associated with good functional outcomes [odds ratio (OR) =3.68, 95% confidence interval (CI): 1.13–12.01, P=0.0309; OR =3.45, 95% CI: 1.06–11.26, P=0.0402, respectively] and a lower risk of HT (OR =0.30, 95% CI: 0.11–0.86, P=0.0253; OR =0.36, 95% CI: 0.13–0.99, P=0.0488, respectively). However, there was no significant difference in all-cause death within 3 months among the three groups (OR =0.84, 95% CI: 0.29–2.46, P=0.7468; OR =0.76, 95% CI: 0.26–2.22, P=0.6104). Additionally, no significant differences were observed between LMDS therapy and HDS therapy regarding good functional outcomes at 3 months (OR =0.94, 95% CI: 0.50–1.77, P=0.8411) and the occurrence of HT (OR =1.19, 95% CI: 0.47–3.02, P=0.7093). The results of the relationship between different statin doses and 3-month good functional outcome were consistent after interaction tests. Conclusions: Our findings provide evidence for the benefit and safety of LMDS therapy in AIS patients with medication treatment alone. LMDS therapy is associated with favorable impacts on 3-month functional outcomes and a reduced risk of HT compared to non-statin therapy. There were no significant differences in achieving 3-month good functional outcome, the risk of HT or death within 3 months were observed between LMDS and HDS therapy in our study. Further studies with prospective design and larger sample sizes are necessary to validate our results.